TABLE 1.
Group | No. of sera with positive result when tested with indicated antigen in dot immunobinding (titer ≥ 20,000)
|
No. of sera with positive result in indicated Widal test
|
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
n | ST O-HSA
|
ST LPS
|
ST O (100 ng) | n | Widal H
|
Widal O
|
|||||
100 ng | 10 ng | 100 ng | 10 ng | ≥1/80 | ≥1/160 | ≥1/80 | ≥1/160 | ||||
Typhoid fever | 40 | 28 | 12 | 38 | 34 | 16 | 35 | 27 | 26 | 25 | 22 |
Nontyphoid fevers | 22 | 2a | 1b | 1a | 1a | 0d | 22 | 7f | 3a | 13 | 6g |
Healthy controls | 17 | 0a | 0c | 0a | 0a | 0g | NDh | ND | ND | ND | ND |
Significantly different from patients with typhoid fever (P < 0.0001; Fisher's exact test).
Significantly different from patients with typhoid fever (P = 0.0226; Fisher's exact test).
Significantly different from patients with typhoid fever (P = 0.0114; Fisher's exact test).
Significantly different from patients with typhoid fever (P = 0.0005; Fisher's exact test).
Significantly different from patients with typhoid fever (P = 0.0012; Fisher's exact test).
Significantly different from patients with typhoid fever (P = 0.001; Fisher's exact test).
Significantly different from patients with typhoid fever (P = 0.014; Fisher's exact test).
ND, not determined.